MARKET

BCTX

BCTX

Briacell Therapeutics Corp
NASDAQ
3.760
-0.130
-3.34%
Opening 13:23 03/27 EDT
OPEN
3.900
PREV CLOSE
3.890
HIGH
3.900
LOW
3.720
VOLUME
203.24K
TURNOVER
--
52 WEEK HIGH
98.20
52 WEEK LOW
3.600
MARKET CAP
27.26M
P/E (TTM)
-0.1155
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCTX last week (0316-0320)?
Weekly Report · 4d ago
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR
TipRanks · 03/18 12:26
BriaCell to present four posters at the 2026 AACR
TipRanks · 03/18 11:42
BriaCell Therapeutics To Present Four Posters At 2026 American Association For Cancer Research Annual Meeting
Benzinga · 03/18 11:35
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/18 11:30
BriaCell reports 9 of 25 Phase 2 metastatic breast cancer patients alive more than 18-47 months post-enrollment
Reuters · 03/17 14:32
Weekly Report: what happened at BCTX last week (0309-0313)?
Weekly Report · 03/16 09:07
BriaCell Therapeutics Q2 FY2026 net loss widens 15% to USD 7.3 million
Reuters · 03/10 21:09
More
About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTX stock methods without spending real money on the virtual paper trading platform.